Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients

References

• Parekh VB, Niyyar VD, Vachharajani TJ. Lower extremity permanent dialysis vascular access. Clin J Am Soc Nephrol. 2016;11(9):1–7. doi: 10.2215/CJN.01780216.
   PubMed Web of Science ®Google Scholar
• Sumida K, Yamagata K, Iseki K, et al. Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients. Nephrol Dial Transplant. 2016;31(2):298–305. doi: 10.1093/ndt/gfv402.
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3 Suppl 1):A7–A8. doi: 10.1053/j.ajkd.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69(7):1222–1228. doi: 10.1038/sj.ki.5000186.
   PubMed Web of Science ®Google Scholar
• Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79(2):250–257. doi: 10.1038/ki.2010.383.
   PubMed Web of Science ®Google Scholar
• Assimon MM, Wenger JB, Wang L, et al. Ultrafiltration rate and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2016;68(6):911–922. doi: 10.1053/j.ajkd.2016.06.020.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Okuda Y, Sy J, et al. Ultrafiltration rate, residual kidney function, and survival among patients treated with Reduced-Frequency hemodialysis. Am J Kidney Dis. 2020;75(3):342–350. doi: 10.1053/j.ajkd.2019.08.019.
   PubMed Web of Science ®Google Scholar
• KDOQI. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50(3):471–530. doi: 10.1053/j.ajkd.2007.06.008.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Pisoni RL, Combe C, et al. Anaemia in haemodialysis patients of five european countries: association with morbidity and mortality in the dialysis outcomes and practice patterns study (DOPPS) [published correction appears in nephrol dial transplant. 2004 jun;19(6):1666]. Nephrol Dial Transplant. 2004;19(1):121–132. doi: 10.1093/ndt/gfg458.
   PubMed Web of Science ®Google Scholar
• Buttarello M, Pajola R, Novello E, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol. 2010;133(6):949–954. doi: 10.1309/AJCPQAX0JFHFS0OA.
   PubMed Web of Science ®Google Scholar
• Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989;35(1):134–148. doi: 10.1038/ki.1989.18.
   PubMed Web of Science ®Google Scholar
• Chan KE, Maddux FW, Tolkoff-Rubin N, et al. Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol. 2011;6(11):2642–2649. doi: 10.2215/CJN.03680411.
   PubMed Web of Science ®Google Scholar
• Hu PJ, Chen YW, Chen TT, et al. Impact of dialysis modality on major adverse cardiovascular events and all-cause mortality: a national population-based study. Nephrol Dial Transplant. 2021;36(5):901–908. doi: 10.1093/ndt/gfaa282.
   PubMed Web of Science ®Google Scholar
• Navarrete JE, Rajabalan A, Cobb J, et al. Proportion of hemodialysis treatments with high ultrafiltration rate and the association with mortality. Kidney360. 2022;3(8):1359–1366. Published 2022 May 5. doi: 10.34067/KID.0001322022.
   PubMedGoogle Scholar
• Lertdumrongluk P, Streja E, Rhee CM, et al. Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients. Clin J Am Soc Nephrol. 2015;10(7):1179–1191. doi: 10.2215/CJN.09000914.
   PubMed Web of Science ®Google Scholar
• Kuipers J, Verboom LM, Ipema KJR, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with Meta-Analysis. Am J Nephrol. 2019;49(6):497–506. doi: 10.1159/000500877.
   PubMed Web of Science ®Google Scholar
• European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant. 2002;17Suppl(7):16–31.
   Google Scholar
• Kramer H, Yee J, Weiner DE, et al. Ultrafiltration rate thresholds in maintenance hemodialysis: an NKF-KDOQI controversies report. Am J Kidney Dis. 2016;68(4):522–532. doi: 10.1053/j.ajkd.2016.06.010.
   PubMed Web of Science ®Google Scholar
• Lankhorst CE, Wish JB. Anemia in renal disease: diagnosis and management. Blood Rev. 2010;24(1):39–47. doi: 10.1016/j.blre.2009.09.001.
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006;116(2):288–296. doi: 10.1172/JCI27699.
   PubMed Web of Science ®Google Scholar
• Weiner DE, Tighiouart H, Vlagopoulos PT, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005;16(6):1803–1810. doi: 10.1681/ASN.2004070597.
   PubMed Web of Science ®Google Scholar
• Mikhail A, Brown C, Williams JA, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease. BMC Nephrol. 2017;18(1):345. Published 2017 Nov 30. doi: 10.1186/s12882-017-0688-1.
   PubMed Web of Science ®Google Scholar
• Zhao X, Niu Q, Gan L, et al. Baseline data report of the China dialysis outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873. Published 2021 Jan 13. doi: 10.1038/s41598-020-79531-4.
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang J, Wang S, et al. High erythropoiesis resistance index is a significant predictor of cardiovascular and all-cause mortality in chinese maintenance hemodialysis patients. Mediators Inflamm. 2020;2020:1027230–1027237. Published 2020 Nov 26. doi: 10.1155/2020/1027230.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Nitta K. Erythropoiesis-stimulating agent hyporesponsiveness in end-stage renal disease patients. Contrib Nephrol. 2015;185:76–86. doi: 10.1159/000380972.
   PubMed Web of Science ®Google Scholar
• Batchelor EK, Kapitsinou P, Pergola PE, et al. Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol. 2020;31(3):456–468. doi: 10.1681/ASN.2019020213.
   PubMed Web of Science ®Google Scholar
• Kimachi M, Fukuma S, Yamazaki S, et al. Minor elevation in C-Reactive protein levels predicts incidence of Erythropoiesis-Stimulating agent hyporesponsiveness among hemodialysis patients [published correction appears in nephron. 2016;132(4):342]. Nephron. 2015;131(2):123–130. doi: 10.1159/000438870.
   PubMed Web of Science ®Google Scholar
• Al-Hilali N, Al-Humoud H, Ninan VT, et al. Does parathyroid hormone affect erythropoietin therapy in dialysis patients? Med Princ Pract. 2007;16(1):63–67. doi: 10.1159/000096143.
   PubMed Web of Science ®Google Scholar
• Rattanasompattikul M, Molnar MZ, Zaritsky JJ, et al. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant. 2013;28(7):1936–1945. doi: 10.1093/ndt/gfs368.
   PubMed Web of Science ®Google Scholar
• Assimon MM, Flythe JE. Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base. Curr Opin Nephrol Hypertens. 2015;24(6):525–530. doi: 10.1097/MNH.0000000000000174.
   PubMed Web of Science ®Google Scholar
• McIntyre CW, Harrison LE, Eldehni MT, et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(1):133–141. doi: 10.2215/CJN.04610510.
   PubMed Web of Science ®Google Scholar
• Jefferies HJ, Crowley LE, Harrison LE, et al. Circulating endotoxaemia and frequent haemodialysis schedules. Nephron Clin Pract. 2014;128(1-2):141–146. doi: 10.1159/000366519.
   PubMed Web of Science ®Google Scholar
• McIntyre CW, Odudu A. Hemodialysis-associated cardiomyopathy: a newly defined disease entity. Semin Dial. 2014;27(2):87–97. doi: 10.1111/sdi.12197.
   PubMed Web of Science ®Google Scholar
• Hussein WF, Arramreddy R, Sun SJ, et al. Higher ultrafiltration rate is associated with longer dialysis recovery time in patients undergoing conventional hemodialysis. Am J Nephrol. 2017;46(1):3–10. doi: 10.1159/000476076.
   PubMed Web of Science ®Google Scholar